Toca5: A Phase 2/3 Randomized, Open Label Study of Toca 511™, a Retroviral Replicating Vector,
Combined With Toca FC™ versus Standard of Care in Subjects Undergoing Planned
Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
The Tocagen trial has just opened! Our website and clinicaltrials.gov do not have the details yet, but if you are interested in this trial, call them and ask where it is being done. This is for people with recurrent GBM or Anaplastic Astrocytoma, who are going to have surgery. There is a video on how this works at http://www.tocagen.com/toca5/
This is one of my favorite new trials. (Disclaimer: Tocagen is a sponsor of the Musella Foundation)
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.tocagen.com/toca5/
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines